- Home
- STAI vs OSRH Comparison
STAI vs OSRH Comparison
Compare STAI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAI
- OSRH
- Stock Information
- Founded
- STAI 2011
- OSRH N/A
- Country
- STAI United States
- OSRH United States
- Employees
- STAI N/A
- OSRH N/A
- Industry
- STAI
- OSRH
- Sector
- STAI
- OSRH
- Exchange
- STAI Nasdaq
- OSRH Nasdaq
- Market Cap
- STAI 16.4M
- OSRH 19.0M
- IPO Year
- STAI N/A
- OSRH N/A
- Fundamental
- Price
- STAI $0.58
- OSRH $0.64
- Analyst Decision
- STAI
- OSRH
- Analyst Count
- STAI 0
- OSRH 0
- Target Price
- STAI N/A
- OSRH N/A
- AVG Volume (30 Days)
- STAI 19.5M
- OSRH 1.4M
- Earning Date
- STAI 01-01-0001
- OSRH 08-24-2025
- Dividend Yield
- STAI N/A
- OSRH N/A
- EPS Growth
- STAI N/A
- OSRH N/A
- EPS
- STAI N/A
- OSRH N/A
- Revenue
- STAI $907,637.00
- OSRH N/A
- Revenue This Year
- STAI N/A
- OSRH N/A
- Revenue Next Year
- STAI N/A
- OSRH N/A
- P/E Ratio
- STAI N/A
- OSRH N/A
- Revenue Growth
- STAI 247.64
- OSRH N/A
- 52 Week Low
- STAI $0.56
- OSRH $0.63
- 52 Week High
- STAI $9.07
- OSRH $13.40
- Technical
- Relative Strength Index (RSI)
- STAI N/A
- OSRH N/A
- Support Level
- STAI N/A
- OSRH N/A
- Resistance Level
- STAI N/A
- OSRH N/A
- Average True Range (ATR)
- STAI 0.00
- OSRH 0.00
- MACD
- STAI 0.00
- OSRH 0.00
- Stochastic Oscillator
- STAI 0.00
- OSRH 0.00
About STAI ScanTech AI Systems Inc. Common stock
ScanTech AI Systems Inc is developing and deploying security screening systems that protect travelers and other public members from criminals, terrorists, and other bad actors. It has developed a proprietary Computed Tomography scanning system that uses fixed-gantry technology to detect explosives, weapons, narcotics, and other contraband.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.